David H. Gultekin, Ph.D. - Publications

Affiliations: 
2002 Yale University, New Haven, CT 
Area:
Imaging Science

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Gultekin DH, Siegel PH. Absorption of 5G Radiation in Brain Tissue as a Function of Frequency, Power and Time Ieee Access. 8: 115593-115612. DOI: 10.1109/Access.2020.3002183  0.32
2014 Konstantinidis IT, Do RK, Gultekin DH, Gönen M, Schwartz LH, Fong Y, Allen PJ, D'Angelica MI, DeMatteo RP, Klimstra DS, Kemeny NE, Jarnagin WR. Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials. Annals of Surgical Oncology. 21: 2675-83. PMID 24664624 DOI: 10.1245/S10434-014-3649-Y  0.355
2013 Gollub MJ, Cao K, Gultekin DH, Kuk D, Gonen M, Sohn M, Schwartz LH, Weiser MR, Temple LK, Nash GM, Guillem JG, Wang M, Garcia-Aguilar J, Goodman K, Paty PB. Prognostic aspects of DCE-MRI in recurrent rectal cancer. European Radiology. 23: 3336-44. PMID 23979104 DOI: 10.1007/S00330-013-2984-X  0.328
2013 Donati OF, Jung SI, Vargas HA, Gultekin DH, Zheng J, Moskowitz CS, Hricak H, Zelefsky MJ, Akin O. Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy? Radiology. 268: 440-50. PMID 23481164 DOI: 10.1148/Radiol.13122149  0.376
2013 Gultekin DH, Moeller L. NMR imaging of cell phone radiation absorption in brain tissue. Proceedings of the National Academy of Sciences of the United States of America. 110: 58-63. PMID 23248293 DOI: 10.1073/Pnas.1205598109  0.371
2013 Gollub MJ, Gultekin DH, Schwartz LH. Letter to the Editor re: Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer. European Radiology. 23: 1297-8. PMID 23179526 DOI: 10.1007/S00330-012-2716-7  0.302
2013 Gültekin DH. Nuclear magnetic resonance imaging of absorption of electromagnetic radiation in brain tissue Journal of Experimental & Clinical Medicine. 30: 269. DOI: 10.5835/Jecm.Omu.30.03.015  0.384
2012 Gollub MJ, Gultekin DH, Akin O, Do RK, Fuqua JL, Gonen M, Kuk D, Weiser M, Saltz L, Schrag D, Goodman K, Paty P, Guillem J, Nash GM, Temple L, et al. Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer. European Radiology. 22: 821-31. PMID 22101743 DOI: 10.1007/S00330-011-2321-1  0.338
2011 Akin O, Gultekin DH, Vargas HA, Zheng J, Moskowitz C, Pei X, Sperling D, Schwartz LH, Hricak H, Zelefsky MJ. Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results. European Radiology. 21: 1970-8. PMID 21533634 DOI: 10.1007/S00330-011-2130-6  0.36
2011 Yopp AC, Schwartz LH, Kemeny N, Gultekin DH, Gönen M, Bamboat Z, Shia J, Haviland D, D'Angelica MI, Fong Y, DeMatteo RP, Allen PJ, Jarnagin WR. Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response. Annals of Surgical Oncology. 18: 2192-9. PMID 21286939 DOI: 10.1245/S10434-011-1570-1  0.423
2011 Gultekin DH, Gore JC. Simultaneous measurements of thermal conductivity, thermal diffusivity and specific heat by nuclear magnetic resonance imaging Thermochimica Acta. 519: 96-102. DOI: 10.1016/J.Tca.2011.02.041  0.516
2010 Yopp AC, Schwartz LH, Kemeny NE, Gultekin D, Gonen M, Bamboat Z, Shia J, D'Angelica MI, DeMatteo RP, Jarnagin WR. Dynamic contrast enhanced MRI (DCE-MRI) to measure antiangiogenic therapy and predict treatment response in primary liver cancer (PLC). Journal of Clinical Oncology. 28: e14537-e14537. DOI: 10.1200/Jco.2010.28.15_Suppl.E14537  0.331
2010 Gultekin DH, Gore JC. Measurement of specific heat and specific absorption rate by nuclear magnetic resonance Thermochimica Acta. 503: 100-107. DOI: 10.1016/J.Tca.2010.03.015  0.519
2009 Jarnagin WR, Schwartz LH, Gultekin DH, Gönen M, Haviland D, Shia J, D'Angelica M, Fong Y, Dematteo R, Tse A, Blumgart LH, Kemeny N. Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 20: 1589-95. PMID 19491285 DOI: 10.1093/Annonc/Mdp029  0.389
2009 Gultekin DH, Raidy TE, Gore JC. Effects of radiation on the NMR relaxation effects of aqueous solutions of gadolinium contrast agents. Contrast Media & Molecular Imaging. 4: 33-6. PMID 19061179 DOI: 10.1002/Cmmi.259  0.431
2008 Gultekin DH, Gore JC. Measurement of heat transfer coefficients by nuclear magnetic resonance. Magnetic Resonance Imaging. 26: 1323-8. PMID 18524523 DOI: 10.1016/J.Mri.2008.04.006  0.501
2006 Gultekin DH, Gore JC. Measurement of thermal diffusivity by magnetic resonance imaging. Magnetic Resonance Imaging. 24: 1203-7. PMID 17071342 DOI: 10.1016/J.Mri.2006.03.014  0.526
2005 Gultekin DH, Gore JC. Temperature dependence of nuclear magnetization and relaxation. Journal of Magnetic Resonance (San Diego, Calif. : 1997). 172: 133-41. PMID 15589416 DOI: 10.1016/J.Jmr.2004.09.007  0.468
Show low-probability matches.